| Session |
Date |
|---|---|
| Renal Effects of SGLT2 Inhibition | 01/11/2023 - 12:00pm to 1:00pm EST |
| Coronary In-Stent Restenosis | 01/18/2023 - 12:00pm to 1:00pm EST |
| Choosing a method for Guiding PCI | 01/25/2023 - 12:00pm to 1:00pm EST |
| Dapagiflozin in Heart Failure with Mildly Reduced or Preserved Ejection | 02/01/2023 - 12:00am to 1:00pm EST |
| Risk factors for Atrial arrhythmias in Adults with Ebstein Anomaly | 02/08/2023 - 12:00pm to 1:00pm EST |
| Types of Morphology of Bicuspid AV and Implications for TAVR or SAVR | 02/15/2023 - 12:00pm to 1:00pm EST |
| MYOCARDITIS | 02/22/2023 - 12:00pm to 1:00pm EST |
| EXPANDING CARDIOVASCULAR GUIDELINES to EMBRACE EQUITY | 03/01/2023 - 12:00pm to 1:00pm EST |
| Management of Patients at Risk for and With Left Ventricular Thrombus | 03/08/2023 - 12:00pm to 1:00pm EST |
| Updates in treatment of ATTR amyloidosis | 03/15/2023 - 12:00pm to 1:00pm EDT |

Facebook
X
LinkedIn
Forward